Skip to main content
. 2020 Mar 30;91(6):622–630. doi: 10.1136/jnnp-2019-322038

Table 1.

List of antidopaminergic medication included in this analysis

Drug Number of patients on each drug
Group 1 (n=466*) Group 2 (n=90*)
On two or more of the below 175 53
Tetrabenazine 188 28
Sulpiride 34 16
Haloperidol 66 19
Olanzapine 156 49
Tiapride 118 27
Risperidone 98 51
Quetiapine 45 8

Group 1: patients on antidopaminergic medication throughout the study. Group 2: patients started on antidopaminergic medications part way through the study.

*Some patients were on more than one of the drugs.